In this webinar, hosted by MA Healthcare, Dr Catherine Heffernan addresses influenza vaccine effectiveness using differentiated vaccine technologies.
This online CPD event is free to attend and available on-demand to watch at a time that suits you. Simply click the button below to view.This session has been sponsored by Seqirus, is intended for HCP’s and other relevant decision makers and will include discussion of products.
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events relating to Seqirus products should also be reported to Seqirus UK Limited on 01748 828816.
Click below for prescribing information:
Adjuvanted quadrivalent influenza vaccine (surface antigen, inactivated) Seqirus, prescribing information aQIV-Prescribing-Information.pdf (seqirus.com)
Cell-based quadrivalent influenza vaccine (surface antigen, inactivated) Seqirus, prescribing information QIVc-Prescribing-Information.pdf (seqirus.com)